Xagenic Inc. Closes $10 Million Series A Financing
By Xagenic Canada Inc.
Funding will support development of on-demand molecular diagnostic system and lead tests; changes to Board of Directors announced
27 Appointees Named To Ontario's Highest Honour
Original news from Government of Ontario: http://news.ontario.ca/mci/en/2012/01/27-appointees-named-to-ontarios-highest-honour.html
Three-time Toronto Mayor, David Crombie, former Ontario opposition leader John Tory, and popular bilingual children's educator Suzanne "Marie-Soleil" Pinel are among 27 Ontarians being appointed to The Order of Ontario.
2011 Steacie Prize awarded for nanotechnology-enabled disease diagnosis: Pharmacy's Shana Kelley third consecutive U of T professor to win prestigious science and engineering award
From Nanotechnology Now: http://www.nanotech-now.com/news.cgi?story_id=44102
Western researchers lead sequencing of genome for second-largest group of animals
From University of Western Ontario: http://ow.ly/7DomN
Wednesday, November 23, 2011
An international consortium led by a researcher at The University of Western Ontario has unveiled the first genome of the second-largest group of animals on Earth: Chelicerates.
Exceptional contributions to cancer research recognized
From Canada News Wire: http://www.newswire.ca/en/story/882973/exceptional-contributions-to-cancer-research-recognized
TORONTO, Nov. 23, 2011 /CNW/ - The Canadian Cancer Research Alliance (CCRA) announced today the recipients of its inaugural awards, which recognize contributions to cancer research in Canada.
Next-generation Database of Genomic Variants launches
October 19, 2011
TORONTO – Version 2 of the Database of Genomic Variants (DGV) launches this week. DGV – also known as “the Toronto Database” – is a public resource that facilitates the translation of genomic information into new diagnostic, prognostic and therapeutic tools for improving health. DGV was initially created in 2004, as an initiative of The Centre for Applied Genomics (TCAG) at The Hospital for Sick Children (SickKids) and the University of Toronto’s McLaughlin Centre.
Toronto researchers first to discover new genetic clue in the development of rheumatoid arthritis
Findings will help lead to personalized therapies for common, complex illnesses characterized by abnormal immune responses
Toronto, ON, August 14 - Scientists at Mount Sinai Hospital, in collaboration with researchers at the University of Toronto, University Health Network and McGill University have obtained significant new insights into the causes of rheumatoid arthritis (RA) and other autoimmune disorders including type 1 diabetes, lupus and Graves disease.
